Clinical Trial Update: AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for AZA plus venetoclax as maintenance therapy in younger adults with AML in first remission (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia in Remission

Drugs mentioned

• AZA (azacitidine)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia (AML) in Remission | Phase 2, Phase 3 | Status: RECRUITING